Latest Director Loans News

Page 1 of 7
Genmin has secured another A$1.0 million in unsecured loans from entities associated with two directors, taking total director-associated borrowings to A$4.0 million. The funding provides interim working capital, but strategic partner negotiations for Baniaka remain non-binding and uncertain.
Maxwell Dee
Maxwell Dee
18 Nov 2026
Zelira Therapeutics has only A$47,000 in cash after a quarterly operating outflow of A$56,000, while the proposed US$32.98 million HOPE 1 fundraising remains unclosed. The company says the funds are needed for an FDA application and Phase 1 trial, as its ASX quotation suspension continues.
Victor Sage
Victor Sage
30 Oct 2026
Nutritional Growth Solutions has cut quarterly net operating cash outflow by 54% while completing its Sprout Organic acquisition just after quarter end. The enlarged group starts with US$1.613 million in cash, no borrowings and a substantially larger share base.
Victor Sage
Victor Sage
30 Oct 2026
Vectus Biosystems has secured FDA acceptance of a pre-IND Type B meeting for VB0004, a key regulatory step for its idiopathic pulmonary fibrosis programme. The biotech ended September with $410,000 in cash and reported estimated funding for just 1.33 quarters of operations.
Ada Torres
Ada Torres
29 Oct 2026
Empire Resources has reported a busy September quarter at Yuinmery, with notable copper, gold and palladium-platinum intersections alongside rare earth oxide results reaching 1,712.5ppm TREO+Y. The exploration push comes as the company prepares more drilling and an updated resource estimate while holding $2.571 million in cash.
Maxwell Dee
Maxwell Dee
27 Oct 2026
Volt Resources has secured a $1.5 million placement to fund its Alabama high-purity graphite refinery study, advance pilot work and reduce debt. Almost half the raise is subscribed by two directors, although their participation still requires shareholder approval.
Victor Sage
Victor Sage
13 Oct 2026
Askari Metals cut its annual loss by half, but the improvement came alongside continued cash burn, heavy equity issuance and an auditor-highlighted material uncertainty over its ability to continue as a going concern. The company is now relying on further funding while it prepares exploration programs in Ethiopia and Namibia.
Maxwell Dee
Maxwell Dee
30 Sept 2026
VBX has expanded the Wuudagu Bauxite Project’s resource to 143.2 million tonnes, but its FY26 accounts expose acute funding pressure, with just $301,208 in cash and an auditor warning of material uncertainty over going concern. The definitive feasibility study has been pushed into the first quarter of 2027 while the company relies on fresh equity, related-party funding and prospective strategic partners.
Maxwell Dee
Maxwell Dee
29 Sept 2026
Empire Resources has expanded its Yuinmery exploration story with new copper, gold and PGE zones, but its FY2026 annual report carries a material uncertainty over whether the company can continue as a going concern. A $4.825 million capital raising lifted cash, yet losses and director-related debt also increased.
Maxwell Dee
Maxwell Dee
29 Sept 2026
Vectus Biosystems swung to a $1.56 million FY2026 profit, but the result was driven largely by the sale of its VB4-P5 compound for XORTX shares and warrants rather than recurring operations. The company is now directing its resources towards VB0004 while its auditor flags material uncertainty over ongoing funding.
Ada Torres
Ada Torres
18 Sept 2026
Globe Metals & Mining has locked in a US$600,000 unsecured working capital facility from director Bo Tan, adding short-term financial flexibility as it advances its Kanyika Niobium Project.
Maxwell Dee
Maxwell Dee
4 Aug 2026
Jade Gas Holdings has secured regulatory approvals for Mongolia’s first coal bed methane reserves, completed a A$12 million capital raise, and signed a non-binding A$1.1 billion collaboration agreement to fund initial development of its Red Lake gasfield.
Maxwell Dee
Maxwell Dee
31 July 2026

Browse the archive

Full archive